ASSESSING THE VALUE OF 24-HOUR CHRONIC PAIN CONTROL FROM THE PATIENT PERSPECTIVE- DO EXISTING PATIENT-REPORTED OUTCOMES INSTRUMENTS ADEQUATELY COVER THE RELEVANT CONCEPTS RELATED TO 24-HOUR CHRONIC PAIN CONTROL?

Author(s)

Annette Lam, MS, Manager, World-Wide Health Economics & Pricing (Pain)1, Isabelle Guillemin, PhD, Scientific Writer2, Ute Richarz, MD, Global Medical Affairs Lead3, Shane Kavanagh, BSc, (Hons), MSc, Director, Health Economics Group4, Marie-Pierre Emery, MSc, Director, Information Resources Centre Director5, Khadra Benmedjahed, BA, Senior Project Manager2, Dominique Dubois, MD, Director Worldwide Health Economics & Pricing CNS/Internal Medicine4, Benoit Arnould, PhD, Operations Director21Johnson & Johnson Pharmaceutical Services, Toronto, ON, Canada; 2 Mapi Values, Lyon, France; 3 Johnson & Johnson Pharmaceutical Services, Baar, Switzerland; 4 Johnson & Johnson Pharmaceutical Services, Beerse, Belgium; 5 Mapi Research Trust, Lyon, France

OBJECTIVES: One of the challenges for innovation in chronic pain treatment is to provide consistent pain control over a 24-hour period. How does this clinical objective translate into concepts relevant to patients, and do the existing instruments adequately capture these concepts? METHODS: Thirty face-to-face exploratory interviews were conducted by psychologists in France, Germany and the UK with patients with chronic pain (cancer-related pain excluded) to collect information on how they describe the course of pain over 24 hours and how changes in pain levels and the time they occur affects their everyday lives. In parallel, a list of related concepts and a description of the conceptual contents of existing instruments was extracted from the literature. RESULTS: Analysis of the patient interviews resulted in the identification of several concepts related to 24-hour pain control which are closely intertwined with one another: type of pain (background, breakthrough, and end-of-dose pain), description (occurrence, intensity, sensation), worsening, relieving, triggering factors, impact of pain (particularly patients’ activities of daily living, sleep and mood), pain medication (efficacy, time to efficacy, duration of efficacy, frequency medication is taken) and pain over time (evolution over one day). Most of these concepts are partially or extensively covered by existing instruments. However, no instrument is comprehensive enough to be used as a standalone measure. CONCLUSIONS: The control of 24-hour pain is complex and requires multidimensional assessment. Despite the considerable number of pain questionnaires available, no specific measurement instrument exists that fully addresses the concerns of patients. To accurately capture the benefits of once-daily treatments in pain control, researchers need either a new instrument, or the adaptation of a series of existing questionnaires to form a consistent and comprehensive battery.

Conference/Value in Health Info

2008-11, ISPOR Europe 2008, Athens, Greece

Value in Health, Vol. 11, No. 6 (November 2008)

Code

PSY50

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Systemic Disorders/Conditions

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×